David Kang, PHARM D in Thousand Oaks, CA - Pharmacist

David Kang, PHARM D is a Pharmacist based in Thousand Oaks, California. David Kang is licensed to practice in California (license number 65046) and his current practice location is 550 N Ventu Park Rd, Thousand Oaks, California. He can be reached at his office (for appointments etc.) via phone at (805) 375-4052.

NPI number for David Kang is 1124303706 and his current mailing address is 9453 Megan Ave, Chatsworth, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1124303706.

Contact Information

	David Kang, PHARM D
	550 N Ventu Park Rd, Thousand Oaks, CA 91320-2709
	(805) 375-4052
	Not Available

Healthcare Provider's Profile

Full Name	David Kang
Gender	Male
Speciality	Pharmacist
Location	550 N Ventu Park Rd, Thousand Oaks, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1124303706
Provider Enumeration Date: 10/14/2011
Last Update Date: 10/14/2011

Medical Identifiers

Medical identifiers for David Kang such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1124303706	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	65046 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. David Kang is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
David Kang, PHARM D 9453 Megan Ave, Chatsworth, CA 91311-5737 Ph: () -	David Kang, PHARM D 550 N Ventu Park Rd, Thousand Oaks, CA 91320-2709 Ph: (805) 375-4052

News Archive

NIHR grant to support the development of the BRC's CRIS system

The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.

Growing emergency room ‘access block' problem in Australian hospitals

Shockingly the number of Australians who die waiting for a hospital bed is on par with road deaths said a senior Canberra emergency department doctor. According to Australian National University medical school's road trauma chairman, Associate Professor Drew Richardson, 30 per cent of emergency wards' work now involves caring for patients whose initial treatment has ended but still await a bed. He suggested a seven-day-a-week surgical roster to avoid the build-ups of patients that overcrowd wards.

Shire announces FDA PDUFA date for FIRAZYR NDA in treatment of acute attacks of hereditary angioedema

Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.

Multifunctional polymer nanoparticles pass critical in vivo test

In an effort to overcome the drug resistance that often occurs in cancer, a team of investigators has developed a nanoparticle made of a blend of polymers that first releases a powerful anticancer drug and then delivers an agent that tricks a drug-resistant cell into committing suicide. Now, tests in mice with human breast cancer have shown that these blended nanoparticles are effective in maintaining high levels of both drugs in the vicinity of tumors.

VRC scientists receive $2.2M grant to develop new resin composite dental fillings

The American Dental Association and the ADA Foundation today announced that the foundation's Anthony Volpe Research Center (VRC) received a five-year, $2.2 million grant from the National Institute of Dental and Craniofacial Research (NIDCR) to develop new resin composite dental fillings.

Pharmacist in Thousand Oaks, CA

Joshua Miles, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2220 Lynn Rd Ste 101, Thousand Oaks, CA 91360 Phone: 805-495-1015
Dr. Juliana Jamira Gheorghiu, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 279 Hodencamp Rd, 26, Thousand Oaks, CA 91360 Phone: 805-557-0699
Dr. Sally Jo Miller, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1793 E Avenida De Las Flores, Thousand Oaks, CA 91362 Phone: 678-523-7553
Grace T Mayemura, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 512 N Ventu Park Rd, Thousand Oaks, CA 91320 Phone: 805-262-3413
Mr. Kevin Mark Nagengast, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 60 Rancho Rd Ste 7, Thousand Oaks, CA 91362 Phone: 805-379-9200 Fax: 805-379-3900
Richard Velasco, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 N Ventu Park Rd, Thousand Oaks, CA 91320 Phone: 805-375-4052 Fax: 805-376-2785
Elnaz Rabanian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2791 Agoura Rd, Thousand Oaks, CA 91361 Phone: 805-495-4938

David Kang, PHARM D - Pharmacist in Thousand Oaks, CA